Umeclidinium and Vilanterol Inhalation Powder - Indications, Contraindications, Pharmacology Aspects, Warnings and Precautions
The combination of umeclidinium and Vilanterol eases COPD symptoms by opening the airways. Umeclidinium is an anticholinergic, and Vilanterol is an LABA.
Vilanterol - Usage, Mechanism of Action, Precautions, and Side Effects
Vilanterol has been approved for use in combination with Fluticasone furoate for the management of asthma and COPD (chronic obstructive pulmonary disease).